{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:42:50Z","timestamp":1792096970357,"version":"4.4.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>Malassezia are common yeasts in human skin microbiome. Under certain conditions these yeasts may cause disease from skin disorders to systemic infections. In the absence of clinical breakpoints, epidemiological cutoff values (ECVs) are useful to differentiate isolates with acquired or mutational resistance. The aim of this work was to propose tentative ECVs of Malassezia furfur, M. sympodialis, M. globosa for fluconazole (FCZ), itraconazole (ITZ), voriconazole (VCZ), ketoconazole (KTZ) and amphotericin B (AMB). A total of 160 isolates (80\u00a0M. furfur, 50\u00a0M. sympodialis, and 30\u00a0M. globosa) were tested. Minimal inhibitory concentrations (MICs) were determined by modified broth microdilution method (CLSI). ECVs were estimated by ECOFFinder software and twofold dilutions beyond the mode. ITZ, KTZ, and VCZ showed the lowest MICs. The highest MIC and widest ranges were for FCZ and AMB. For ITZ, KTZ, and VCZ both ECVs were similar. For FCZ, AMB especially M. furfur, modal ECVs were lower than values obtained by statistical method. When MIC distribution is the only data available, ECV could provide information to help guide therapy decisions. In that drug\/species combination in which different peaks in the MIC distribution were observed, difference between both ECV was greater. This is the first study that provides ECV data of 160 Malassezia yeasts. Although ECVs cannot be used as predictors of clinical response, identification of non wild-type isolates suggests that it may be less likely to respond to a given antifungal agent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay Summary<\/jats:title>\n                  <jats:p>Malassezia species causes skin disorders to systemic infections. Epidemiological cutoff value (ECV) allows for differentiation of wild-type and non wild-type isolates. Based on MIC data of 160 isolates we propose tentative ECVs for three Malassezia species. ECVs are useful in surveillance and guide therapy decisions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mmy\/myac048","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T18:56:55Z","timestamp":1656615415000},"source":"Crossref","is-referenced-by-count":7,"title":["<i>Malassezia<\/i> species: the need to establish epidemiological cutoff values"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7362-6755","authenticated-orcid":false,"given":"Florencia Dinorah","family":"Rojas","sequence":"first","affiliation":[{"name":"Departamento de Micolog\u00eda, Instituto de Medicina Regional, Universidad Nacional del Nordeste, CONICET. Resistencia, 3500 , Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda de los \u00c1ngeles","family":"Sosa","sequence":"additional","affiliation":[{"name":"Departamento de Micolog\u00eda, Instituto de Medicina Regional, Universidad Nacional del Nordeste, Resistencia, 3500 , Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenceslao","family":"Latorre","sequence":"additional","affiliation":[{"name":"Departamento de Micolog\u00eda, Instituto de Medicina Regional, Universidad Nacional del Nordeste, Resistencia, 3500 , Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mussin","sequence":"additional","affiliation":[{"name":"Departamento de Micolog\u00eda, Instituto de Medicina Regional, Universidad Nacional del Nordeste, CONICET. Resistencia, 3500 , Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Alegre","sequence":"additional","affiliation":[{"name":"Departamento de Micolog\u00eda, Instituto de Medicina Regional, Universidad Nacional del Nordeste, Resistencia, 3500 , Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Giusiano","sequence":"additional","affiliation":[{"name":"Departamento de Micolog\u00eda, Instituto de Medicina Regional, Universidad Nacional del Nordeste, CONICET. Resistencia, 3500 , Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"2022080813043425000_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature12171","article-title":"Topographic diversity of fungal and bacterial communities in human skin","volume":"498","author":"Findley","year":"2013","journal-title":"Nature"},{"key":"2022080813043425000_bib2","doi-asserted-by":"crossref","first-page":"e1003892","DOI":"10.1371\/journal.ppat.1003892","article-title":"Malassezia yeasts: how many species infect humans and animals?","volume":"10","author":"Caba\u00f1es","year":"2014","journal-title":"PLoS Pathog"},{"key":"2022080813043425000_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-03616-3","volume-title":"Malassezia and the Skin","author":"Boekhout","year":"2010"},{"key":"2022080813043425000_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/CMR.00021-11","article-title":"The malassezia genus in skin and systemic diseases","volume":"25","author":"Gaitanis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2022080813043425000_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jaad.2003.12.034","article-title":"Skin diseases associated with malassezia species","volume":"51","author":"Gupta","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2022080813043425000_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1399-3062.2009.00404.x","article-title":"Malassezia: is it a pulmonary pathogen in the stem cell transplant population?","volume":"11","author":"Blaes","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"2022080813043425000_bib7","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1099\/jmm.0.078709-0","article-title":"In vitro antifungal susceptibility of malassezia furfur from bloodstream infections","volume":"63","author":"Iatta","year":"2014","journal-title":"J Med Microbiol"},{"key":"2022080813043425000_bib8","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/mmy\/myx134","article-title":"Malassezia ecology, pathophysiology, and treatment","volume":"56","author":"Theelen","year":"2018","journal-title":"Med Mycol"},{"key":"2022080813043425000_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.riam.2014.01.002","article-title":"Fungemia and interstitial lung compromise caused by malassezia sympodialis in a pediatric patient","volume":"32","author":"Aguirre","year":"2015","journal-title":"Rev Iberoam Micol"},{"key":"2022080813043425000_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2022080813043425000_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fcimb.2020.00370","article-title":"Malassezia spp. Yeasts of emerging concern in fungemia","volume":"10","author":"Rhimi","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2022080813043425000_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00079","article-title":"Malassezia yeasts in veterinary dermatology: an updated overview","volume":"10","author":"Guillot","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2022080813043425000_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcp.2010.12.003","article-title":"Advances in the identification of malassezia","volume":"25","author":"Cafarchia","year":"2011","journal-title":"Mol Cell Probes"},{"key":"2022080813043425000_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/13693780701191373","article-title":"Update on the genus malassezia","volume":"45","author":"Ashbee","year":"2007","journal-title":"Med Mycol"},{"key":"2022080813043425000_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/0019-5154.110841","article-title":"Identification and speciation of malassezia in patients clinically suspected of having pityriasis versicolor","volume":"58","author":"Shah","year":"2013","journal-title":"Indian J Dermatol"},{"key":"2022080813043425000_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijantimicag.2006.09.016","article-title":"Antifungal activities of azole agents against the malassezia species","volume":"29","author":"Miranda","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"2022080813043425000_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/AAC.44.2.467-469.2000","article-title":"In vitro activities of ketoconazole, econazole, miconazole, and melaleuca alternifolia (Tea tree) oil against malassezia species","volume":"44","author":"Hammer","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2022080813043425000_bib18","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1128\/JCM.42.8.3589-3593.2004","article-title":"Use of fatty acid RPMI 1640 media for testing susceptibilities of eight malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and etest","volume":"42","author":"Velegraki","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2022080813043425000_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/mmy\/myu010","article-title":"Antifungal susceptibility of malassezia furfur, malassezia sympodialis, and malassezia globosa to azole drugs and amphotericin b evaluated using a broth microdilution method","volume":"52","author":"Rojas","year":"2014","journal-title":"Med Mycol"},{"key":"2022080813043425000_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/mmy\/myv049","article-title":"Azole susceptibility of malassezia pachydermatis and malassezia furfur and tentative epidemiological cut-off values","volume":"53","author":"Cafarchia","year":"2015","journal-title":"Med Mycol"},{"key":"2022080813043425000_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/mmy\/myu089","article-title":"In vitro activity of two amphotericin b formulations against malassezia furfur strains recovered from patients with bloodstream infections","volume":"53","author":"Iatta","year":"2015","journal-title":"Med Mycol"},{"key":"2022080813043425000_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/myc.12556","article-title":"Antifungal susceptibility testing of malassezia yeast: comparison of two different methodologies","volume":"60","author":"Rojas","year":"2017","journal-title":"Mycoses"},{"key":"2022080813043425000_bib23","article-title":"Performance standards for antifungal susceptibility testing of yeasts","volume-title":"CLSI M60","author":"CLSI","year":"2020","edition":"2"},{"key":"2022080813043425000_bib24","article-title":"Performance standards for antifungal susceptibility testing of filamentous fungi","volume-title":"CLSI supplement M61","author":"CLSI","year":"2020","edition":"2"},{"key":"2022080813043425000_bib25","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/JCM.02416-16","article-title":"Establishment and use of epidemiological cutoff values for molds and yeasts by use of the clinical and laboratory standards institute M57 standard","volume":"55","author":"Lockhart","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2022080813043425000_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.riam.2016.04.001","article-title":"The role of epidemiological cutoff values (ECVs\/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds","volume":"33","author":"Espinel-Ingroff","year":"2016","journal-title":"Rev Iberoam Micol"},{"key":"2022080813043425000_bib27","article-title":"Principles and procedures for the development of epidemiological cutoff values for antifungal susceptibility testing","volume-title":"CLSI M57","author":"CLSI","year":"2017","edition":"1"},{"key":"2022080813043425000_bib28","article-title":"Epidemiological cutoff values for antifungal susceptibility testing","volume-title":"CLSI supplement M59","author":"CLSI","year":"2020","edition":"3"},{"key":"2022080813043425000_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.riam.2013.02.002","article-title":"Prevalencia de especies de malassezia asociadas a lesiones de dermatitis seborreica en pacientes de argentina","volume":"30","author":"Sosa M de los","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"2022080813043425000_bib30","article-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","volume-title":"CLSI M27 A4","author":"CLSI","year":"2020","edition":"4"},{"key":"2022080813043425000_bib31","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"2022080813043425000_bib32","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.00248-12","article-title":"Wild-Type MIC distributions and epidemiological cutoff values for amphotericin b, flucytosine, and itraconazole and candida spp. as determined by CLSI broth microdilution","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2022080813043425000_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.01256-09","article-title":"Echinocandin susceptibility testing of candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media","volume":"54","author":"Arendrup","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2022080813043425000_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00485-17","article-title":"Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for candida auris and associated tentative epidemiological cutoff values","volume":"61","author":"Arendrup","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022080813043425000_bib35","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/jac\/dkv140","article-title":"Stepwise emergence of azole, echinocandin and amphotericin b multidrug resistance in vivo in candida albicans orchestrated by multiple genetic alterations","volume":"70","author":"Jensen","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2022080813043425000_bib36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Resistance to antifungal agents: mechanisms and clinical impact","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2022080813043425000_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/myc.12577","article-title":"The role of drug efflux pumps in malassezia pachydermatis and malassezia furfur defence against azoles","volume":"60","author":"Iatta","year":"2017","journal-title":"Mycoses"},{"key":"2022080813043425000_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1128\/AAC.31.6.951","article-title":"In vitro activity of systemic antifungal agents against malassezia furfur","volume":"31","author":"Marcon","year":"1987","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myac048\/44359071\/myac048.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/8\/myac048\/45288809\/myac048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/8\/myac048\/45288809\/myac048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T13:05:02Z","timestamp":1659963902000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myac048\/6623669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,8]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myac048","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8]]},"published":{"date-parts":[[2022,6,30]]},"article-number":"myac048"}}